ArticleMolecular therapy oncolytics2023

A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling.

Sven H Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.